Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Report ID | 213113 |
Drug Identification Number | 02408813 |
Brand name | CISATRACURIUM OMEGA MULTIDOSE |
Common or Proper name | Cisatracurium Besylate Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CISATRACURIUM |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 x 10mL vial / fiole |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-12-12 |
Estimated end date | 2024-05-15 |
Actual end date | 2024-04-01 |
Shortage status | Resolved |
Updated date | 2024-07-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2024-07-09 | English | Compare |
v12 | 2024-04-02 | English | Compare |
v11 | 2024-04-01 | French | Compare |
v10 | 2024-04-01 | English | Compare |
v9 | 2024-02-20 | English | Compare |
v8 | 2023-12-13 | French | Compare |
v7 | 2023-12-13 | English | Compare |
v6 | 2023-12-13 | English | Compare |
v5 | 2023-12-12 | French | Compare |
v4 | 2023-12-12 | English | Compare |
v3 | 2023-12-12 | French | Compare |
v2 | 2023-12-12 | English | Compare |
v1 | 2023-12-12 | English | Compare |
Showing 1 to 13 of 13